Literature DB >> 27290736

Efficacy of a Tubeless Patch Pump in Patients With Type 2 Diabetes Previously Treated With Multiple Daily Injections.

Jennifer E Layne1, Christopher G Parkin2, Howard Zisser1.   

Abstract

Entities:  

Keywords:  CSII; HbA1c; MDI; insulin resistance; patch pump; type 2 diabetes

Mesh：

Substances：

Year:  2016        PMID： 27290736      PMCID： PMC5375063          DOI： 10.1177/1932296816653143

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  6 in total

1.  Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysis.

Authors:  Peter Lynch; Aylin Altan Riedel; Navendu Samant; Ying Fan; Tim Peoples; Jenifer Levinson; Scott W Lee
Journal:  Prim Care Diabetes       Date:  2010-09-15       Impact factor: 2.459

2.  Patient perceptions of using the OmniPod system compared with conventional insulin pumps in young adults with type 1 diabetes.

Authors:  Yael Lebenthal; Liora Lazar; Hadassa Benzaquen; Shlomit Shalitin; Moshe Phillip
Journal:  Diabetes Technol Ther       Date:  2012-01-27       Impact factor: 6.118

3.  Reduction of glycosylated hemoglobin following 6 months of continuous subcutaneous insulin infusion in an Indian population with type 2 diabetes.

Authors:  Jothydev Kesavadev; Shyam Balakrishnan; Shebeer Ahammed; Sunitha Jothydev
Journal:  Diabetes Technol Ther       Date:  2009-08       Impact factor: 6.118

4.  Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure.

Authors:  E Berthe; B Lireux; C Coffin; B Goulet-Salmon; D Houlbert; S Boutreux; S Fradin; Y Reznik
Journal:  Horm Metab Res       Date:  2007-03       Impact factor: 2.936

5.  Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial.

Authors:  Yves Reznik; Ohad Cohen; Ronnie Aronson; Ignacio Conget; Sarah Runzis; Javier Castaneda; Scott W Lee
Journal:  Lancet       Date:  2014-07-02       Impact factor: 79.321

6.  Efficacy of the Omnipod Insulin Management System on Glycemic Control in Patients With Type 1 Diabetes Previously Treated With Multiple Daily Injections or Continuous Subcutaneous Insulin Infusion.

Authors:  Jennifer E Layne; Christopher G Parkin; Howard Zisser
Journal:  J Diabetes Sci Technol       Date:  2016-08-22
  6 in total
  7 in total

1.  Patch Pumps: Are They All the Same?

Authors:  Lutz Heinemann; Delia Waldenmaier; Bernd Kulzer; Ralph Ziegler; Barry Ginsberg; Guido Freckmann
Journal:  J Diabetes Sci Technol       Date:  2018-08-22

2.  Treatment Intensification With Insulin Pumps and Other Technologies in Patients With Type 2 Diabetes: Results of a Physician Survey in the United States.

Authors:  George Grunberger; David Sze; Anastasia Ermakova; Ray Sieradzan; Teresa Oliveria; Eden M Miller
Journal:  Clin Diabetes       Date:  2020-01

3.  Key Features of Insulin Delivery Devices for Type 2 Diabetes: Type 2.0 Booth Survey.

Authors:  David Sze; Teresa Oliveria
Journal:  Clin Diabetes       Date:  2020-01

4.  Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age.

Authors:  Trang T Ly; Jennifer E Layne; Lauren M Huyett; David Nazzaro; Jason B O'Connor
Journal:  J Diabetes Sci Technol       Date:  2018-09-21

5.  Safety and Effectiveness of an Investigational Insulin Delivery Device Providing Basal/Bolus Therapy with Rapid-Acting or Regular Human Insulin in Adults with Type 2 Diabetes.

Authors:  Ronnie Aronson; Edward Mahoney; Drilon Saliu; David Sze; Didier Morel; Leya Bergquist; Laurence Hirsch
Journal:  Diabetes Technol Ther       Date:  2020-03-11       Impact factor: 6.118

6.  Phenolic Preservative Removal from Commercial Insulin Formulations Reduces Tissue Inflammation while Maintaining Euglycemia.

Authors:  Adam Mulka; Brianne E Lewis; Li Mao; Roshanak Sharafieh; Shereen Kesserwan; Rong Wu; Donald L Kreutzer; Ulrike Klueh
Journal:  ACS Pharmacol Transl Sci       Date:  2021-04-26

7.  Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion.

Authors:  Grazia Aleppo; Christopher G Parkin; Anders L Carlson; Rodolfo J Galindo; Davida F Kruger; Carol J Levy; Guillermo E Umpierrez; Gregory P Forlenza; Janet B McGill
Journal:  Diabetes Technol Ther       Date:  2021-06-17       Impact factor: 6.118
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.